<bill session="112" type="h" number="6502" updated="2012-11-24T14:29:58-05:00">
	<state datetime="2012-09-21">REFERRED</state>
	<status><introduced datetime="2012-09-21"/></status>

	<introduced datetime="2012-09-21"/>
	<titles>
		<title type="short" as="introduced">Life-Threatening Diseases Compassion through Combination Therapy Act of 2012</title>
		<title type="official" as="introduced">To amend title V of the Federal Food, Drug, and Cosmetic Act to provide for extensions of marketing exclusivity periods for drugs in certain combinations of such drugs, and for other purposes.</title>
	</titles>
	<sponsor id="400570"/>
	<cosponsors>
		<cosponsor id="400103" joined="2012-09-21"/>
		<cosponsor id="400251" joined="2012-09-21"/>
	</cosponsors>
	<actions>
		<action datetime="2012-09-21" state="REFERRED"><text>Referred to the House Committee on Energy and Commerce.</text></action>
		<action datetime="2012-09-26"><committee name="House Committee on Energy and Commerce"/><text>Referred to the Subcommittee on Health.</text></action>
	</actions>
	<committees>
		<committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee" />
		<committee code="" name="House Energy and Commerce" subcommittee="Health" activity="Referral" />
	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>
		<term name="Health"/>
		<term name="Administrative law and regulatory procedures"/>
		<term name="Advisory bodies"/>
		<term name="Department of Health and Human Services"/>
		<term name="Drug and radiation therapy"/>
		<term name="Drug safety, medical device, and laboratory regulation"/>
		<term name="Food and Drug Administration (FDA)"/>
		<term name="Government information and archives"/>
		<term name="Government investigations"/>
		<term name="Health information and medical records"/>
		<term name="Intellectual property"/>
		<term name="Medical research"/>
		<term name="Prescription drugs"/>
	</subjects>
	<amendments>

	</amendments>
	<summary>
	
	</summary>
</bill>
